Assessing the efficacy of specific cerebellomodulatory drugs for use as therapy for spinocerebellar ataxia type 1. [electronic resource]
Producer: 20130613Description: 74-82 p. digitalISSN:- 1473-4230
- Amantadine -- pharmacology
- Animals
- Ataxin-1
- Ataxins
- Buspirone -- pharmacology
- Disease Models, Animal
- Dopamine Agents -- pharmacology
- Genotype
- Hypnotics and Sedatives -- pharmacology
- Kyphosis -- genetics
- Male
- Mice
- Mice, Inbred C57BL
- Mice, Transgenic
- Motor Activity -- drug effects
- Nerve Tissue Proteins -- genetics
- Neuroprotective Agents -- pharmacology
- Nuclear Proteins -- genetics
- Phenotype
- Purkinje Cells -- drug effects
- Pyridines -- pharmacology
- Riluzole -- pharmacology
- Serotonin Receptor Agonists -- pharmacology
- Spinocerebellar Ataxias -- drug therapy
- Zolpidem
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.